Purity
99.3%
Mol. Weight
4604.2 Da
Form
Prefilled Klik-Pen
Amino Acid Sequence
RETAKLIK contains retatrutide (LY3437943), a novel triple-acting receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. Each pen contains 30mg/2.4ml (4 doses of 7.5mg). The glucagon receptor component adds thermogenic and lipolytic effects beyond what dual agonists achieve. Phase 2 clinical data demonstrated unprecedented weight reduction of up to 24% at 48 weeks. Research focuses on obesity, NASH/MAFLD, and metabolic syndrome.
Available Variants
| SKU | Dosage | Price (AED) | Status |
|---|---|---|---|
| RET-1PEN | 30mg | AED 850 | AVAILABLE |
| RET-3PK | 3x30mg | AED 2,295 | AVAILABLE |
Research Use Only. All products listed on this platform are intended solely for in-vitro research and laboratory use. They are not intended for human or animal consumption, medical diagnosis, or therapeutic application. By accessing this site, you confirm you are a qualified researcher or authorized procurement agent. No statements have been evaluated by any regulatory authority. Purchasers assume all responsibility for compliance with applicable local, national, and international regulations.